NEUROPEPTIDE RESEARCH

Selank vs DSIP: A Neuropeptide Research Comparison

Velox Peptides Research Team·Updated June 2026·8 min read
Selank
Tuftsin analogue
DSIP
Delta sleep-inducing peptide
Shared class
Neuropeptides
HPLC Purity
≥99% (both)
For in vitro research use only. This page compares two research peptides by what researchers have observed in preclinical studies — not therapeutic effects. It is not medical advice and makes no therapeutic or human-use claims. Neither compound is supplied for human or veterinary consumption.

Quick verdict

Both Selank and DSIP are neuropeptides — peptides (short chains of amino acids, the building blocks of proteins) that act on nerve cells — and both have been studied in preclinical animal models. The big difference is the pathway each one is studied for: Selank (a synthetic copy of the immune peptide tuftsin) is studied for anxiety-related behaviour through the brain’s GABA and BDNF pathways, while DSIP (Delta Sleep-Inducing Peptide) is studied for delta-wave sleep (the slow brain waves of deep sleep), the stress response, and antioxidant pathways (the body’s system for mopping up harmful molecules). So if a study is about anxiety-like behaviour, Selank is the closer fit; if it is about deep sleep, stress or oxidative pathways, DSIP is. These are research observations only, not therapeutic effects.

Overview: why these two are compared

Selank and DSIP are both small neuropeptides that researchers reach for when studying the brain, behaviour and stress in animal models. People compare them because they sit in nearby corners of the same field — calming-and-stress research — but they are studied for different things. Selank is studied mostly for anxiety-like behaviour and the pathways behind it. DSIP is studied mostly for sleep, and for how the body handles stress and oxidative damage. Everything described here is what researchers have observed in preclinical studies, not effects in people.

Origin and structure

Selank is a synthetic (lab-made) peptide of seven amino acids (a heptapeptide), built as an analogue (a close copy) of the natural immune peptide tuftsin, with a Pro-Gly-Pro tail added to make it last longer. Because it comes from tuftsin, Selank is studied for effects on both behaviour and the immune system. See the full Selank research overview.

DSIP (Delta Sleep-Inducing Peptide) is a naturally-occurring peptide of nine amino acids (a nonapeptide) first isolated from the brains of rabbits during deep sleep. It is named after the delta brain waves of deep sleep that it was first linked to in animal experiments. See the full DSIP research overview.

Mechanism: anxiolytic pathways vs sleep and stress pathways

Why it matters: the pathways each peptide is studied for are the clearest way to tell them apart, because they line up directly with the research question — anxiety-like behaviour on one side, sleep and the stress response on the other.

Selank — GABA/BDNF anxiolytic pathways

The most studied thing about Selank is how it acts on the GABA system — the brain’s main “calming” pathway — and on BDNF, a protein that helps nerve cells survive and form connections. In rodent studies it eased anxiety-like behaviour without the heavy drowsiness caused by benzodiazepines (a common class of sedatives). These are research observations only, not therapeutic effects.

DSIP — delta-wave sleep, stress response and antioxidant pathways

DSIP’s standout feature in animal models is its link to delta-wave (deep) sleep activity. Preclinical work has also looked at how it interacts with the stress-response system and with antioxidant pathways — the cell’s defences against harmful, reactive molecules. So DSIP is the tool for studying sleep, stress and oxidative pathways. These are research observations only, not therapeutic effects.

The verdict on mechanism

The two cover neighbouring ground: Selank leans toward easing anxiety-like behaviour, DSIP leans toward sleep and the stress response. A study that spans both anxiety and sleep or stress is the classic reason to look at them side by side.

Side-by-side comparison

PropertySelankDSIP
Class / sequenceSynthetic heptapeptide (7 amino acids), Thr-Lys-Pro-Arg-Pro-Gly-ProNaturally-occurring nonapeptide (9 amino acids), Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
OriginSynthetic analogue of the immune peptide tuftsinNaturally-occurring peptide, first isolated from sleeping rabbit brain
Primary pathways studiedGABAergic and BDNF (anxiety-related)Delta-wave sleep, stress-response and antioxidant pathways
Typical research modelsRodent anxiety models (e.g. elevated-plus-maze)Rodent sleep, stress and oxidative-stress models
Stability / formLyophilised (freeze-dried) white powder; Pro-Gly-Pro tail aids stabilityLyophilised (freeze-dried) white powder; short half-life in models
Often studied alongsideSemax, other neuropeptidesSelank, Epitalon and other neuropeptides

Key research findings

Here are some example preclinical studies for each one, summarised for science reference only.

Selank — anxiolytic activity
Seredenin SB, Kozlovskaya MM et al. — Selank anxiolytic activity in rodent anxiety models

Reported anxiolytic-like effects in rodent models without the motor impairment or sedation of classical anxiolytics — a research observation, not a therapeutic effect.

PMID: 19916388

Selank — BDNF & memory
Kozlovskaya et al. — Selank and BDNF regulation in the hippocampus and prefrontal cortex in rats. 2019

Linked Selank’s behavioural effects in rats to BDNF regulation, connecting it to the GABA/BDNF pathway picture.

PMID: 31625062

DSIP — sleep and behaviour
Literature search — Delta Sleep-Inducing Peptide and delta-wave sleep modulation in animal models

Preclinical reports describe DSIP’s association with delta-wave (deep) sleep activity and stress-response pathways in rodents — research observations only.

PubMed: DSIP sleep studies

DSIP — antioxidant pathways
Literature search — Delta Sleep-Inducing Peptide and antioxidant / oxidative-stress pathways

Animal-model studies have examined DSIP in the context of stress and antioxidant (oxidative-stress) pathways — describing what researchers observed, not effects in people.

PubMed: DSIP antioxidant studies

Studied together / which to study

Because Selank and DSIP cover neighbouring areas — anxiety-related GABA/BDNF pathways versus sleep, stress and antioxidant pathways — researchers working across stress, behaviour and sleep sometimes examine them alongside each other. Both belong to the neuropeptide research category. Any combined use is strictly for in vitro research, never for human or veterinary use.

Study Selank when the research question is about anxiety-like behaviour, the GABA system, or BDNF signalling in rodent models.

Study DSIP when the research question is about delta-wave (deep) sleep, the stress-response system, or antioxidant pathways in animal models.

References & key literature

  1. Seredenin SB, Kozlovskaya MM et al. Selank anxiolytic activity in rodent anxiety models. PMID: 19916388
  2. Kozlovskaya et al. Selank and BDNF regulation in the hippocampus and prefrontal cortex in rats. 2019. PMID: 31625062
  3. Delta Sleep-Inducing Peptide & delta-wave sleep modulation — PubMed search: delta sleep-inducing peptide sleep
  4. Delta Sleep-Inducing Peptide & antioxidant / stress pathways — PubMed search: delta sleep-inducing peptide antioxidant

Summaries are paraphrased from the publicly available preclinical literature. For full source citations, email veloxpeps@gmail.com.

Frequently asked questions

What is the difference between Selank and DSIP?
Both are neuropeptides studied in preclinical animal models. Selank (a synthetic analogue of the immune peptide tuftsin) is studied for anxiolytic-related GABA and BDNF pathway activity in rodents. DSIP (Delta Sleep-Inducing Peptide) is studied for delta-wave sleep modulation, stress-response and antioxidant pathway effects in animal models. Both are for in vitro research use only.
Can Selank and DSIP be studied together?
They are sometimes examined alongside each other in stress and behaviour research, since Selank covers anxiety-like behaviour via GABA/BDNF pathways and DSIP covers sleep and stress-response pathways. Any combined use is strictly for in vitro research, not for human use.
Which is studied for sleep research?
DSIP (Delta Sleep-Inducing Peptide) is the sleep-focused peptide, studied in animal models for modulating delta-wave (deep) sleep activity and stress-response pathways. Selank is studied more for anxiety-like behaviour via GABAergic and BDNF pathways.
Are Selank and DSIP legal to buy in the UK?
Yes — both are legal to purchase in the UK for in vitro research purposes. They are not licensed medicines and not approved for human use. Velox Peptides supplies them solely as research reagents.
What purity are Velox Peptides Selank and DSIP?
Both are third-party HPLC-verified to a minimum of 99% purity, with a batch certificate of analysis available on request.
Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.

All research summaries on this page are derived from publicly available peer-reviewed literature. Velox Peptides makes no therapeutic claims. For research use only.